Ryan Zimmerman
Stock Analyst at BTIG
(3.97)
# 563
Out of 5,148 analysts
244
Total ratings
53.59%
Success rate
9.91%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KIDS OrthoPediatrics | Maintains: Buy | $23 → $24 | $19.22 | +24.87% | 11 | Feb 27, 2026 | |
| ORGO Organogenesis Holdings | Maintains: Buy | $9 → $8 | $3.00 | +166.67% | 11 | Feb 27, 2026 | |
| SOLV Solventum | Reiterates: Buy | $100 | $73.00 | +36.99% | 3 | Feb 27, 2026 | |
| ENOV Enovis | Maintains: Buy | $41 → $43 | $25.70 | +67.32% | 2 | Feb 26, 2026 | |
| ALC Alcon | Maintains: Buy | $91 → $92 | $84.68 | +8.64% | 14 | Feb 25, 2026 | |
| GKOS Glaukos | Reiterates: Buy | $131 | $121.12 | +8.16% | 17 | Feb 18, 2026 | |
| TCMD Tactile Systems Technology | Maintains: Buy | $36 → $38 | $29.29 | +29.74% | 6 | Feb 18, 2026 | |
| ZBH Zimmer Biomet Holdings | Reiterates: Buy | $112 | $99.49 | +12.57% | 11 | Feb 10, 2026 | |
| MDAI Spectral AI | Reiterates: Buy | $3 | $1.41 | +112.77% | 3 | Feb 10, 2026 | |
| HUMA Humacyte | Reiterates: Buy | $6 | $1.12 | +435.71% | 7 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $91 | $80.16 | +13.52% | 6 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $410 → $412 | $387.02 | +6.45% | 19 | Jan 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $616 | $496.25 | +24.13% | 23 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $349 | $342.30 | +1.96% | 21 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $13.37 | +79.51% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $1.92 | - | 4 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $5.27 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $1.5 | $0.57 | +162.51% | 3 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.66 | - | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $75.45 | - | 2 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $195 | $128.46 | +51.80% | 1 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $35.36 | - | 9 | Sep 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $25.90 | - | 2 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $13.53 | +69.99% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $145 → $148 | $114.12 | +29.69% | 7 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.61 | - | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $93.80 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $10.43 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $19.05 | +178.22% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.37 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $175.40 | +14.03% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $245.45 | +42.60% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $98.10 | +30.48% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $11.99 | +25.10% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.44 | +140.83% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $7.77 | +575.68% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $30.65 | - | 3 | Apr 2, 2020 |
OrthoPediatrics
Feb 27, 2026
Maintains: Buy
Price Target: $23 → $24
Current: $19.22
Upside: +24.87%
Organogenesis Holdings
Feb 27, 2026
Maintains: Buy
Price Target: $9 → $8
Current: $3.00
Upside: +166.67%
Solventum
Feb 27, 2026
Reiterates: Buy
Price Target: $100
Current: $73.00
Upside: +36.99%
Enovis
Feb 26, 2026
Maintains: Buy
Price Target: $41 → $43
Current: $25.70
Upside: +67.32%
Alcon
Feb 25, 2026
Maintains: Buy
Price Target: $91 → $92
Current: $84.68
Upside: +8.64%
Glaukos
Feb 18, 2026
Reiterates: Buy
Price Target: $131
Current: $121.12
Upside: +8.16%
Tactile Systems Technology
Feb 18, 2026
Maintains: Buy
Price Target: $36 → $38
Current: $29.29
Upside: +29.74%
Zimmer Biomet Holdings
Feb 10, 2026
Reiterates: Buy
Price Target: $112
Current: $99.49
Upside: +12.57%
Spectral AI
Feb 10, 2026
Reiterates: Buy
Price Target: $3
Current: $1.41
Upside: +112.77%
Humacyte
Feb 9, 2026
Reiterates: Buy
Price Target: $6
Current: $1.12
Upside: +435.71%
Feb 9, 2026
Reiterates: Buy
Price Target: $91
Current: $80.16
Upside: +13.52%
Jan 30, 2026
Maintains: Buy
Price Target: $410 → $412
Current: $387.02
Upside: +6.45%
Jan 23, 2026
Reiterates: Buy
Price Target: $616
Current: $496.25
Upside: +24.13%
Jan 16, 2026
Downgrades: Neutral
Price Target: $349
Current: $342.30
Upside: +1.96%
Dec 15, 2025
Reiterates: Buy
Price Target: $24
Current: $13.37
Upside: +79.51%
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $1.92
Upside: -
Nov 20, 2025
Upgrades: Neutral
Price Target: n/a
Current: $5.27
Upside: -
Nov 11, 2025
Maintains: Buy
Price Target: $2 → $1.5
Current: $0.57
Upside: +162.51%
Nov 7, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.66
Upside: -
Oct 21, 2025
Reiterates: Neutral
Price Target: n/a
Current: $75.45
Upside: -
Oct 13, 2025
Maintains: Buy
Price Target: $190 → $195
Current: $128.46
Upside: +51.80%
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $35.36
Upside: -
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $25.90
Upside: -
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $13.53
Upside: +69.99%
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $114.12
Upside: +29.69%
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $7.61
Upside: -
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $93.80
Upside: -
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $10.43
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $19.05
Upside: +178.22%
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $13.37
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $175.40
Upside: +14.03%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $245.45
Upside: +42.60%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $98.10
Upside: +30.48%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $11.99
Upside: +25.10%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.44
Upside: +140.83%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $7.77
Upside: +575.68%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $30.65
Upside: -